baber/WOPTO huggingface dataset:
Patent ES-2358429-T3 (ES)
Inventor: KRUSE GERHARD
IPC: H04B7/005
Filed: 2005-02-08
Granted: 2011-05-10
Abstract: A method and device for operating MIMO air interfaces in mobile communications systems, according to which a radio signal is transmitted by a transmitting device via a MIMO channel comprising a number of m subchannels and is received by a receiving device having n antennas. Different polarizations are assigned to the signals to be transmitted on the subchannels, and the signals are supplied to a common antenna.
Patent ES-2373665-T3 (ES)
Inventor: NYLANDER TOMAS
IPC: H04W64/00
Filed: 2005-02-25
Granted: 2012-02-07
Abstract: The present invention relates to an improved location process for determining the location of mobile stations when a GSM network is extended by other access networks, for example unlicensed radio access networks. An access network controller supporting a connection with the mobile station sends a location service entity a location request that includes information indicative of at least one positioning method supported by the network element for a particular mobile station. By providing the location service entities with information on the location methods to use, there is no need to configure the location service entities with this information in advance. Moreover, the process is flexible and can be tailored to the network element making the request and thus to the type of connection actually used by the mobile station. There is no need for the location entities to launch several location methods before retrieving sufficiently accurate information since the most suitable methods are communicated in advance.
Patent ES-2335899-T3 (ES)
Title: Nueva forma cristalina deacido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabicicl(4.3.0)nonal-8-il)-6-fluoro-1,4-dihidro-4-oxo-3-quinolincarboxilico.
Inventor: RAST HUBERT
IPC: A61K31/4709
Filed: 2005-03-19
Granted: 2010-04-06
Abstract: Medicamentos que contienen trihidrato de pradofloxacino conforme a la reivindicación 1.
Patent ES-2336578-T3 (ES)
Inventor: PEROVITCH PHILIPPE
IPC: A61K9/00
Filed: 2005-01-07
Granted: 2010-04-14
Abstract: Composition comprises pilocarpine and a bioadhesive polymer for local adhesion to buccopharyngeal tissue. ACTIVITY : None given. MECHANISM OF ACTION : None given.
Patent ES-2307160-T3 (ES)
Inventor: BREEBAART DIRK J
IPC: G10L19/008
Filed: 2005-03-25
Granted: 2008-11-16
Abstract: There is described a multi-channel encoder (10; 600) for processing input signals conveyed in N input channels to generate corresponding output signals conveyed in M output channels together with complementary parametric data; M and N are integers wherein N>M. The encoder (10; 600) includes a down-mixer for down-mixing the input signals to generate the corresponding output signals, the encoder also comprising an analyser for processing the input signals to generate the parameter data, said parametric data describing mutual differences between the N channels of input signal to allow for regenerating during decoding one or more of the N channels of input signals from the M channels of output signal. Such an encoder (10; 600) is capable of providing highly efficient data encoding and also of being backwards compatibility with relatively simpler decoders having fewer than N decoding output channels. The invention also concerns decoders (800) compatible with such a multi-channel encoder (10; 600).
Patent ES-2351932-T3 (ES)
Title: Envase múltiple de envoltorios que contienen productos para uso médico.
Inventor: DOTTA ANGELO
IPC: A61F13/02
Filed: 2005-06-24
Granted: 2011-02-14
Abstract: Envase (21) múltiple de envoltorios que contienen productos para uso médico que comprende una envoltura (23) a la que están sujetos al menos dos grupos de dichos envoltorios (25,35) superpuestos entre sí, estando dispuestos dichos grupos de manera que los envoltorios de cada grupo quedan unidos entre sí a lo largo de un lado (25a, 35a) y quedan libres a lo largo del lado (25b, 35b) opuesto de manera que al plegarse aparecen separados, caracterizado porque dichos grupos están sujetos a dicha envoltura (23) de manera que, cuando dicho envase se cierra, dicho lado (25a, 25b) unido de dichos envoltorios (25, 35) de un primer grupo de dichos grupos y dicho lado (25b, 35b) libre de dichos envoltorios (25, 35) de un segundo grupo de dichos grupos se giran en la misma dirección, quedando dichos grupos de envoltorios enfrentados entre sí en dirección invertida.
Patent ES-2671380-T3 (ES)
Title: Estabilización de un procedimiento de hidroformilación
Inventor: PETERSON RONALD R
IPC: C07C45/50
Filed: 2005-07-19
Granted: 2018-06-06
Abstract: Un procedimiento de hidroformilación, que comprende hacer reaccionar uno o más reaccionantes, monóxido de carbono e hidrógeno en presencia de un catalizador de hidroformilación, que comprende un catalizador complejo de metal-ligando de organofósforo, para producir un fluido producto de reacción que comprende uno o más productos, en donde dicho procedimiento se realiza a una presión parcial de monóxido de carbono tal que la velocidad de reacción aumenta según la presión parcial del monóxido de carbono disminuye y la velocidad de reacción disminuye según la presión parcial del monóxido de carbono aumenta; y en donde se realizan las siguientes etapas de procedimiento para estabilizar la velocidad de reacción, presión total, caudal de purga, temperatura de reacción, o una combinación de los mismos; comprendiendo las etapas del procedimiento al menos uno de los siguientes esquemas de control de procedimiento seleccionados de: Esquema A: (a1) establecer una presión total diana; (a2) detectar la presión total y determinar la diferencia entre la presión total detectada y la presión total diana; y (a3) en base a la diferencia de presión medida en la etapa (a2), manipular un caudal de alimentación de gas que comprende monóxido de carbono para ajustar la presión total detectada esencialmente a la presión total diana; y Esquema B: (b1) establecer un caudal de purga diana; (b2) detectar el caudal de purga y determinar la diferencia entre el caudal de purga detectado y el caudal de purga diana; y (b3) en base a la diferencia de caudal de purga medida en la etapa (b2), manipular un caudal de alimentación de gas que comprende monóxido de carbono para ajustar el caudal de purga detectado al caudal de purga diana.
Patent ES-2323247-T3 (ES)
Inventor: ROSCH THOMAS
IPC: F16L37/40
Filed: 2005-09-20
Granted: 2009-07-09
Abstract: The invention relates to a coupling device for connecting line devices, preferably quick connector, having a coupling housing comprising a connecting device that can be connected to an end section of a line device or of a second connecting device, and a valve body which can be transferred from a closed position to an open position when the end section of the line device or of the second connecting device is brought together with the coupling housing. The valve body can be actuated by means of a force deflecting device by bringing the end section of the line device or of the second connecting device together with the coupling housing.
Patent ES-2547449-T3 (ES)
Title: Serie de lentes de contacto asféricas
Inventor: YE MING
IPC: G02C7/04
Filed: 2005-11-21
Granted: 2015-10-06
Abstract: Serie de lentes de contacto, teniendo cada lente en la serie una potencia óptica objetivo dentro del intervalo de - 15 dioptrías a 10 dioptrías para corregir miopía o hipermetropía, incluyendo la serie una primera subserie de lentes que tienen una potencia óptica objetivo de desde 0 hasta 10 dioptrías, una segunda subserie de lentes que tienen una potencia óptica objetivo de desde -1 hasta -6 dioptrías, y una tercera subserie de lentes que tienen una potencia óptica objetivo de desde -6 hasta -15 dioptrías, comprendiendo cada lente en la serie una superficie anterior que tiene una primera zona óptica central y una superficie posterior opuesta que tiene una segunda zona óptica central, en la que las segundas zonas ópticas centrales de todas las lentes en la serie son sustancialmente idénticas entre sí y son superficies asféricas, en las que la primera zona óptica central de cada lente en la serie tiene un diseño asférico que, en combinación con la segunda zona óptica central, proporciona un perfil de potencia óptica que (a) en el caso de una potencia óptica objetivo de desde 0 hasta 10 dioptrías, es un perfil de potencia óptica sustancialmente constante, (b) en el caso de una potencia óptica objetivo de desde -1 hasta -6 dioptrías, es un perfil de potencia que imita el perfil de potencia óptica de una lente esférica con una potencia óptica objetivo idéntica, y (c) en el caso de una potencia óptica objetivo de desde -6 hasta -15 dioptrías, es un perfil de potencia en el que la aberración esférica de la lente a 6 mm de diámetro es de desde aproximadamente 0,65 dioptrías hasta aproximadamente 1,8 dioptrías más negativa que la aberración esférica a 4 mm de diámetro, en la que la segunda zona óptica central de la superficie posterior es una superficie cónica definida por la ecuación (1) en la que S1 es la altura sagital, c1 es la curvatura apical (la recíproca del radio apical), x es la distancia radial desde el vértice, y k1 es una constante cónica, y en la que la primera zona óptica central de la superficie anterior es una superficie definida por la ecuación (2) en la que S2 es la altura sagital, c2 es la curvatura apical (la recíproca del radio apical), x es la distancia radial desde el vértice, k2 es una constante cónica, y a1 a a7 son los coeficientes.
Patent ES-2333978-T3 (ES)
Inventor: FALCAO ESTRADA ERNESTO JOSE DE SOUSA
IPC: A01G25/09
Filed: 2005-12-06
Granted: 2010-03-03
Abstract: Low flow liquid application system for center pivot irrigation systems, based on the installation of micro-micro-sprinklers with variable spacing between them, to evaluate case by case. The size and the water flow of each micro-micro-sprinkler can be constant, its location being defined so that to any micro-micro-sprinkler corresponds an equal ground area. The micro-micro-sprinklers are installed in a system of two feeding and distribution pipes, with filtering and pressure regulation systems, the micro-micro-sprinklers having eventually an individual flow regulation system, depending on the size of the pivot and the ground topographic conditions. The distribution pipe can be installed at a variable high to the ground, for fitting to the existing crops, and the chemical products application can be restricted isolating parts of the distribution pipe if necessary.
Patent ES-2320580-T3 (ES)
Inventor: HICKS ALLEN J
IPC: A61M25/00
Filed: 1996-09-18
Granted: 2009-05-25
Abstract: A tapered single (50) or multi-lumen catheter (10, 70) having a elongated cylindrical tube (28) for injection and removal of fluid, is provided with generally constant diameter internal lumen or lumens (16,18) which are connected to a tip portion (26) which may be a conical tapered tip that smoothly merges with the cylindrical surface of the tube (28) so that insertion trauma and the possibility of kinking are minimized. The catheter body is generally formed of proximal and distal portions wherein the proximal portion includes a portion (30) which increases in external diameter in the proximal direction to provide a strain relief for the intersection of the catheter body (12) and the hub member (20) of the catheter. The portion of the catheter body which increases in diameter may also include one or more lumens therein which are of constant diameter such that the outer wall (32) of the catheter body increases in thickness therealong to increase the columnar strength of the catheter body therealong.
Patent ES-2354261-T3 (ES)
Inventor: TRIVINI RUGGERO
IPC: B60B33/00
Filed: 2006-05-23
Granted: 2011-03-11
Abstract: An improved hubless castor wheel construction, particularly for a furniture article and the like, comprises a rotary element which is pivotably supported by a support element to be associated with a furniture article, said support element comprising two half-shells which can be coupled to locking means and are designed for defining an upright which can be engaged with connecting means to be connected to the furniture article, and an annular attachment for said rotary element.
Patent ES-2340787-T3 (ES)
Inventor: ENDREGAARD EINAR
IPC: B05B13/04
Filed: 2006-06-06
Granted: 2010-06-09
Abstract: The robot has several movable axles and a three dimensionally movable end effector which is fitted with several application devices (11, 12) such as atomisers. The application devices can be mounted side by side at a predetermined spacing and each discharge a spray jet with a predetermined jet width in the same direction. The spray width can be as great as the distance between the application devices to ensure the spray jets overlap for total cover. The spray width can be adjustable and the spray jets can also be fixed so that the spray widths do not overlap. Independent claim describes operating method for multi-axle robot where several applicator devices are guided on the end effector.
Patent ES-2326129-T3 (ES)
Inventor: NELISSEN JOHANNES HENRICUS
IPC: B21L99/00
Filed: 2006-04-26
Granted: 2009-10-01
Abstract: To obtain a compact structure and to increase at the same time the structural stiffness of an apparatus (2) for plastically deforming and strengthening the links (26), which are intercoupled by rocker pins (24), of a complete endless transmission chain (28), said apparatus (2) comprises a first and a second pair respectively of conical supporting surfaces (20,22) for the ends which protrude outside said links (26) of the rocker pins (24) of a transmission chain (28), mounted thereon, said surfaces (20,22) having a controllable mutual distance, the invention propose to add a third similar pair of supporting surfaces (31), provided for cooperation with the first and second shaft (8,10). This measure also speeds up the treatment of the transmission chain (28).
Patent ES-2320373-T3 (ES)
Inventor: FLACTION PATRICK
IPC: A61B5/22
Filed: 2006-03-17
Granted: 2009-05-21
Abstract: The method involves associating a detachable measurement device to loads in movement, during a short test e.g. jump, where the device is electrically automated and based on a tri-axial accelerometer. A sequence of successive acceleration values of the loads along three axes is determined during the test. An amplitude representing muscular capacity and determined from the sequence is indicated on a display (11) e.g. alphanumeric liquid crystal device, of the device. The sequence is converted into another sequence of acceleration along a presumed direction of displacement of the loads. Independent claims are also included for the following: (1) a measurement device for implementing a method for evaluating physiological muscular values of an athlete (2) a system comprising a measurement device for implementing a method for evaluating physiological muscular values of an athlete.
Patent ES-2339583-T3 (ES)
Inventor: HERCOUET LEILA
IPC: A61K8/41
Filed: 2006-05-29
Granted: 2010-05-21
Abstract: Composition for coloring of keratinous fibers comprises an oxidation base such as diamino-N,N-dihydropyrazolone derivatives (I) or their salts and an oxidation dye (II) substituted by a compound containing quaternized nitrogen, in a medium. Composition for coloring of keratinous fibers comprises an oxidation base such as diamino-N,N-dihydropyrazolone derivatives of formula (I) or their salts and an oxidation dye (II) substituted by a compound containing quaternized nitrogen, in a medium. R 1, R 2Q; Q : 1-10C alkyl (optionally substituted by OR 5, NR 6R 7, carboxy, sulfonic, CONR 6R 7, SO 2NR 6R 7, heteroaryl or T), T or 5-6 membered heteroaryl (optionally substituted by 1-4C alkyl or 1-2C alkoxy); or NR 1R 25-7 membered heterocycle (optionally substituted by halo, amino, (di)1-4C alkyl amino, OH, COOH, carboxamido, 1-2C alkoxy or 1-4C alkyl (optionally substituted by OH, amino, (di)alkylamino, alkoxy, carboxy or sulfonyl)); either R 3, R 4H or Q; or NR 3R 4, NR 1R 25-7 membered heterocycle (where the carbons are optionally replaced by O or N and optionally substituted); T : aryl (optionally substituted by 1-4C alkyl, OH, 1-2C alkoxy or (di)1-4C alkyl amino); R 5H, 1-4C alkyl (optionally substituted by 1-2C alkoxy, OH, CONR 8R 9, SO 2R 8 or T) or T; R 6, R 7R 5, CONR 8R 9 or SO 2R 8; and R 8, R 9H, 1-4C alkyl (optionally substituted by OH or 1-2C alkoxy). Independent claims are included for: (1) dyeing of keratinous fibers comprising application of the composition on fibers in the presence of an oxidizing agent; and (2) a device with several compartments comprising the composition and the oxidizing agent in different compartments. [Image].
Patent ES-2427964-T3 (ES)
Inventor: GOETSCH LILIANE
IPC: C12P21/08
Filed: 2003-01-20
Granted: 2013-11-05
Abstract: An isolated antibody (Ab), and its functional fragments, that bind to human insulin-like growth factor-1 receptor (IGF-1R) and optionally: (i) inhibit natural binding of insulin-like growth factors (IGF)-1 and/or -2; and/or (ii) inhibit specifically tyrosine kinase activity of IGF-1R. An isolated antibody (Ab), and its functional fragments, that bind to human insulin-like growth factor-1 receptor (IGF-1R) and optionally inhibit natural binding of insulin-like growth factors (IGF)-1 and/or -2 and/or inhibit specifically tyrosine kinase activity of IGF-1R, is new. Ab comprises: (a) a light chain containing at least one complementarity-determining region (CDR) of one of 3 fully defined sequences comprising 16, 7 or 9 amino acids as given in the specification; or (b) a heavy chain containing at least one of the CDRs of one of 3 fully defined sequences comprising 6, 16 or 8 amino acids as given in the specification or sequences with 80% identity after optimal alignment. Independent claims are also included for the following: (1) murine hybridomas that secrete Ab; (2) an isolated nucleic acid (I) that: (a) is RNA or DNA and encodes Ab or its fragments; (b) is the complement of (a); or (c) has at least 18 nucleotides that can hybridize under stringent conditions with any of six sequences fully defined in the specification that encode the specified CDR, or with sequences having 80% identity after optimal alignment; (3) a vector containing (I); (4) a host cell containing the vector of (3); (5) a non-human transgenic animal containing at least one cell transfected with the vector of (3); (6) producing Ab or its fragments; (7) in vitro diagnosis of diseases induced by over- or under-expression of IGF-1R and or EGFR (epidermal growth factor receptor) by reaction with optionally labeled Ab; and (8) kit for performing method (7). ACTIVITY : Cytostatic; Antipsoriatic. The murine antibody 7C10, specific for IGF-1R, was tested (at 250 Microgram twice a week, intraperitoneally) against MCF-7 breast cancer cells, implanted in nude mice. After 37 days, the mean tumor volume was about 150 mm 3>; compared to about 800 mm 3> for controls and 300 mm 3> for animals treated with 10 Microgram tamoxifen. MECHANISM OF ACTION : Inhibition of signal transduction pathways mediated by IGF-1R, optionally also by epidermal growth factor (EGF) receptor, thus inhibiting growth and/or proliferation of tumor cells, especially where dependent on IGF, EGF, estrogens and/or HER2/neu.
Patent ES-2306401-T3 (ES)
Title: Subconjunto de puesto de conduccion o pilotaje para vehiculo automovil con columna de direccion y dispositivo de visualizacion de informaciones asociado.
Inventor: LE LEIZOUR ALBAN
IPC: B60K37/00
Filed: 2006-11-24
Granted: 2008-11-01
Abstract: Un subconjunto para vehículo automóvil que comprende: un árbol de dirección (16), en la extremidad del cual está solidarizado un volante de dirección (4); una estructura (18) de columna de dirección (5) para el árbol de dirección (16); una envolvente exterior (19), habiendo prevista una abertura (26) en una cara superior (21) de la envolvente exterior (19), y al menos un dispositivo de visualización (23), destinado a la información de los usuarios del vehículo, que presenta una caja (28) solidarizada por encima de la abertura (26), estando situado un borde trasero (36) de la caja (28) por debajo y por detrás de un reborde trasero (35) de la abertura (26), para disimular la abertura (26), caracterizado porque el dispositivo de visualización (23) está solidarizado a la estructura (18) de columna de dirección (5) por medios de fijación (24) que pasan por la abertura (26) para formar una holgura (34), prevista entre el borde trasero (36) de la caja (28) del dispositivo de visualización (23) y el reborde trasero (35) de la abertura (26), de manera que el dispositivo de visualización (23) no esté sometido a las vibraciones que repercuten sobre la envolvente exterior (19) de la columna de dirección (5).
Patent ES-2343691-T3 (ES)
Inventor: KNIPPER-BREER MARLIES
IPC: A61K31/00
Filed: 2006-01-19
Granted: 2010-08-06
Abstract: Use of a compound (I) interacting with brain-derived nerve growth factor (BDNF)-signal transduction cascade for the production of a medicament to treat phantom phenomena of acute tinnitus and/or phantom pain in human or animal. Independent claims are also included for: (1) diagnosing phantom phenomena of the acute tinnitus and/or phantom pain in human or animal, comprising supplying a biological sample, determining the level of the expression of BDNF in the biological sample, comparing the level with a reference value from a healthy organism, and correlating a level lying over the healthy organism with a positive diagnosis; and (2) treating phantom phenomena of the acute tinnitus and/or phantom pain in human or animal, comprising supplying a medicament that exhibits a substance interacting with BDNF signal transduction cascade, and applying the medicament locally to the organism, and optionally repeating the method. ACTIVITY : Auditory; Analgesic. MECHANISM OF ACTION : Brain-derived nerve growth factor (BDNF)-signal transduction cascade blocker; BDNF-signal transduction cascade inhibitor; Gamma aminobutyric acid receptor agonist; L-type-Ca ++>-channel antagonist; Cyclic adenosine monophosphate response element binding protein (CREP) antagonist; Glutamate antagonist; Mitogen activated protein-kinase-inhibitor; Calmodulin-dependent kinase-inhibitor; Tyrosine kinase linked receptor (trkB) antagonist. The ability of (I) to inhibit BDNF-signal transduction cascade was tested in cochlea. (I) Significantly removed the expressions of BNDF Exon-IV.
Patent ES-2421584-T3 (ES)
Title: Un proceso para la preparación de un copolímero de etileno en un reactor tubular
Inventor: NEUTEBOOM PETER
IPC: C08F2/00
Filed: 2006-02-27
Granted: 2013-09-04
Abstract: Un proceso para la preparación de un copolímero de etileno y un monómero copolimerizable con el mismo, caracterizado porque la polimerización tiene lugar en un reactor tubular a una temperatura máxima de entre 290 y 350ºC, el comonómero es un (met)acrilato difuncional o de funcionalidad superior y el comonómero se aplica en una cantidad de entre 0,008% en moles y 0,200% en moles respecto a la cantidad de copolímero de etileno.